Sarah-Taïssir Bencharif: How Can Over 270 Medicines Fit Into The One Critical Medicines Act?
Sarah-Taïssir Bencharif, Physician at Department of Emergency Medicine at Clinics of Europe, shared on LinkedIn:
”As critical as they are different: How can over 270 medicines fit into the one Critical Medicines Act?
It’s been a whirlwind rentrée here in Brussels, and I wouldn’t have it any other way.
I kicked off this month by moderating a fantastic panel session about the proposed Critical Medicines Act and how it could ensure access to such a diversity of therapies, particularly when it comes to medicines derived from substances of human origin, like plasma.
The event, hosted by the Plasma Protein Therapeutics Association (PPTA), brought together policymakers, patients, clinicians, and members of the industry to examine this question.
To start, panelist Marilena Vrana highlighted that plasma-derived medicines, unlike synthetic medicines made in a factory, depend on human donors.
This means that production can’t be ramped up at will, for example.
She emphasized that the legislation should be flexible enough to handle the particularities of such medicines.
On the question of stockpiling of critical medicines, panelist MEP Tomislav Sokol, who is the rapporteur for the file in the European Parliament, emphasized that stockpiling in one country shouldn’t lead to shortages in another, adding that there should be greater coordination between EU countries so patients across the bloc have reliable access.
The audience also heard from panelist Jean-Philippe Plançon, a patient who needs medicines derived from plasma, to better understand just how essential these medicines are.
It’s something panelist Prof. Dr. Isabelle Meyts, who is a pediatric hematologist-oncologist, also sees daily, as she treats children who depend on these medicines.
Both she and Jean-Philippe stressed the need to raise awareness about plasma donation.
It was a fantastic conversation — a warm thank you to each of our panelists and to our audience members for their insights and engagement!
Photo credits: The great Romain Triollet”
Stay updated with Hemostasis Today.
-
Oct 11, 2025, 09:06Natalia Peres Martinez - Surgical Bleed: Replacing Gut Feeling With Guided Thinking
-
Oct 11, 2025, 09:00Muhammad Ali - Hematology In Pakistan: The Silent Revolution In Diagnosis And A Blueprint For Growth
-
Oct 11, 2025, 08:50Robert Zeiser: New Insights and Timeless Lessons in Transplantation
-
Oct 11, 2025, 08:39Mildred Lundgren: These 5 Proposals Are A Clear Road Map for The Future And We Support Them Wholeheartedly
-
Oct 11, 2025, 08:33RPTH Journal: Does Fasting Affect Anticoagulant Therapy? - The Effects Of Fasting During Ramadan
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 11, 2025, 18:47Endovascular Today: SYMPHONY-PE Trial and Advances in Pulmonary Embolism Treatment
-
Oct 11, 2025, 08:49Rodrigo Assar: We Are Pushing the Boundaries by Using Computational Approaches
-
Oct 11, 2025, 08:48Deborah Wild: Thrilled to See GeneVentiv Selected for The NIH NHLBI Catalyze Program
-
Oct 11, 2025, 08:34Ivo Francischetti and Colleagues on Glycoprotein VI Contributing to Platelet Activation in HIT
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 11, 2025, 08:57Jeff June - Seeing The Invisible: How Spatial Biology Is Opening A New Chapter In Stroke Care
-
Oct 11, 2025, 08:11Khaled Musallam: Honored to Be Featured for The 7th Year in A Row in The World’s Top 2% Most-Cited Scientists
-
Oct 11, 2025, 08:07Britta Diebel: This Has Been An Intense, Good Week, Although IPAW Actually Lasts All Year Long
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?